Blog

The latest thoughts from Medicines Law & Policy partners.

The Power of TRIPS Flexibilities in Medicines Procurement

The government of Malaysia has began to roll out treatment of people infected with the hepatitis C virus (HCV).  Treatment will be a combination of...

Commission report on competition enforcement in the pharmaceutical sector

Guest author Jacquelyn D. Veraldi is Assistant Professor of European Law at the University of Groningen. Guest author Tais A. Ruiz Palacios is a...

WHO’s Essential Medicines Committee takes aim at rising prices, adds new treatments for cancer...

On 1 October, the World Health Organization published its latest Model List of Essential Medicines (EML) and Essential Medicines for Children (EMLc). Updated roughly...

Written remarks submitted to the OHCHR following the Expert Workshop on the key challenges...

This blog was submitted by Dr. Katrina Perehudoff, Law Centre for Health and Rights at the University of Amsterdam, and Medicines Law & Policy,...
Fireworks

Wrapping up 2022 with some noteworthy medicines, law and policy events

Welcome to our annual, highly biased, overview of noteworthy events in the field of medicines law and policy. Also in 2022, Covid-19 remained a central...

WTO Members discuss proposal to suspend certain intellectual property protection during the Covid-19 crisis

An earlier version of this comment was published by The Wire on 13 October 2020. On 2 October, India and South Africa sent a proposal...

Trump Administration poses an unprecedented threat to life-saving health programmes 

On his first day in office, US President Trump issued several executive orders, one of which concerns US foreign aid. This order included a...

The Urgency of Compulsory Licensing Provision for Transfer of Technology in the Pandemic Treaty:...

Guest blog by Ronald Eberhard The Intergovernmental Negotiating Body, established by the World Health Assembly, aims to draft a global pandemic prevention, preparedness, and response...

Covid-19 intellectual property pool gaining support

While drug and vaccine developers are working on tools to prevent and treat Covid- 19, here is a question the rest of us should...

Urgent collective action to meet the challenge of this pandemic crisis: a coronavirus related...

The Director-General of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, first described the present coronavirus (COVID-19) outbreak as a pandemic on the 11th...